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Purpose: Chest wall pain and discomfort has been recognized as a significant late
effect of radiation therapy in historical and modern treatment models. Stereotactic Body
Radiotherapy (SBRT) is becoming an important treatment tool in oncology care for patients
with intrathoracic lesions. For lesions in close approximation to the chest wall with motion
management, SBRT techniques can deliver high dose to the chest wall. As an unintended
target of consequence, there is possibility of imposing significant chest wall pain and
discomfort as a late effect of therapy. The purpose of this paper is to evaluate the potential
role of Volume Modulated Arc Therapy (VMAT) technologies in decreasing chest wall dose
in SBRT treatment of pulmonary lesions in close approximation to the chest wall.
Materials and Methods: Ten patients with pulmonary lesions of various sizes and
tomography in close approximation to the chest wall were selected for retrospective
review. All volumes including tumor target, chest wall, ribs, and lung were contoured with
maximal intensity projection maps and four-dimensional computer tomography planning.
Radiation therapy planning consisted of static techniques including Intensity Modulated
Radiation Therapy compared to VMAT therapy to a dose of 60Gy in 12Gy fraction dose.
Dose volume histogram to rib, chest wall, and lung were compared between plans with
statistical analysis.
Results: In all patients, dose and volume were improved to ribs and chest wall using VMAT
technologies compared to static field techniques. On average, volume receiving 30Gy to
the chest wall was improved by 74%; the ribs by 60%. In only one patient did the VMAT
treatment technique increase pulmonary volume receiving 20Gy (V20).
Conclusions: VMAT technology has potential of limiting radiation dose to sensitive chest
wall regions in patients with lesions in close approximation to this structure. This would
also have potential value to lesions treated with SBRT in other body regions where targets
abut critical structures.
Keywords: VolumeModulatedArc Therapy, radiation therapy, intrathoracic lesions, stereotactic body radiotherapy,
chest wall
INTRODUCTION
Radiation therapy is an important treatment modality in can-
cer care. Acute normal tissue effects during therapy generally
affect tissues of rapid self renewal potential including skin and
mucosal surfaces. Late effects from treatment can affect tissues
of both rapid and limited self renewal potential. Injuries to tis-
sues of limited self renewal potential including bone, muscle, and
nerve often become chronic in nature and result in significant
pain with limited successful treatment options. In early breast
cancer management, patients were treated with enface photon
techniques with varied fractionation strategies including strate-
gies not commonly employed in modern care. On occasion, these
patients would develop chest wall injury and rib fracture (Dalinka
et al., 1974; Overgaard, 1988). Even with more modern pre-
IMRT breast cancer therapy techniques, areas of radiation dose
inhomogeneity were identified in medial and lateral rib/chest
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wall/brachial plexus segments with the level of dose inhomogene-
ity exceeding 115% of prescription in significant volumes of the
breast tissue and chest wall. Bone scans obtained at various time
points from therapy would reveal activity in these locations and
anecdotal rib fractures and chest wall soft tissue injury were seen
in this population of patients. Intensity modulation has permitted
improvement in radiation dose distribution in this population.
Improvements in treatment technology including modern image
guidance have re-established the role of accelerated treatment
fractionation schedules in selected patients to strategic targets
including lesions requiring motion management. Stereotactic
radiosurgery (SRS) and radiation therapy have become important
tools for modern care for the oncology patients. Both primary
lesions and metastatic lesions in multiple body areas are success-
fully treated with radiosurgery and stereotactic radiation therapy.
High fraction therapy to limited volumes may have a separate
successful mechanism of tumor cell killing influencing the use of
this form of therapy. High dose limited fraction radiation ther-
apy used in SRS and SBRT is uniquely challenging when tumor
target volumes lie in juxtaposition to normal tissue structures of
limited self renewal potential such as chest wall, rib, and nerve.
In this situation the risk of long-term injury is more likely. Chest
wall injury and pain syndrome can be a significant and debili-
tating effect of therapy with limited treatment options once the
injury becomes clinically apparent. There is increasing evidence
that the risk of chest wall injury is related to the volume of chest
wall receiving high dose radiation as an unintended target. Mutter
and colleagues have recently demonstrated a significant increase
in chest wall injury and pain syndrome driven by the volume
of chest wall receiving 30Gy (V30) (Mutter et al., 2012). Other
investigators have demonstrated similar findings in retrospective
review of radiosurgery treatment plans including issues associated
with body habitus influencing treatment outcome (Voroney et al.,
2009; Dunlap et al., 2010; Welsh et al., 2010).
In this paper, we evaluate the role of Volumetric Modulated
Arc Therapy (VMAT) in limiting radiation dose to the chest wall
volume in patients with pulmonary lesions in close approxima-
tion to the chest wall. The objective is to determine if this plan-
ning strategy may result in quantitative improvement of radiation
dose to the chest wall in this important clinical situation.
MATERIALS AND METHODS
Ten patients with pulmonary lesions in close approximation to
the chest wall (average 2 cm) were chosen in retrospect from our
patient population for this review as these patients appeared suit-
able for this analysis. Eight patients had primary disease of the
lung (Stage 1, non-small cell lung cancer-NSCL) and two patients
hadmetastatic disease with an average age at the time of treatment
of 71 years (range 52–91). As part of the simulation process, all
patients signed consent to permit use of their imaging and radi-
ation therapy planning objects for education and research in a
de-identified format.
MOTION MANAGEMENT
All patients underwent free breathing 4D computer tomogra-
phy radiation therapy planning. For patients with motion less
than 15mm, the clinical target volume (CTV) from the maximal
intensity projection plus motion was chosen as the internal tar-
get volume (ITV). For patients with motion greater than 15mm,
patients were planned with amplitude breathing defined and
reproduced with cone beam CT validation of the target immedi-
ately prior to treatment execution. Planning target volume (PTV)
was 2mm for both planning strategies. Each patient was fitted
with a Vac-loc device (Culver City, IA) fitted with a wingboard
for radiation therapy planning and treatment.
RADIATION THERAPY PLANNING
For static field planning, patients were planned using 50% IMRT
beam strategy and 50% static field. On average, seven fields were
used for treatment plans using static fields. For VMAT plan-
ning, two one-half arcs were used and directed to the same target
volumes.
Optimization constraints included 40Gy to less than 10% of
the chest wall/ribs and 20Gy to less than 20% of the affected lung
volume or better. The constraints were identical for both planning
strategies.
RADIATION THERAPY DOSE
All patients were planned to receive 60Gy in 12Gy fractions used
by both treatment plans for purpose of comparison.
NORMAL TISSUE STRUCTURES
The chest wall was drawn from the inner surface of the rib and
included 2 cm beyond this point from the sternum to the facet
joint of the vertebral body. The rib was drawn as a separate target
by using 4D CT in maximum intensity projection. The lung was
drawn as a separate target. The V20 was calculated relative to the
entire lung volume in the affected lung and compared between
each plan. The V30 of the chest wall and rib was compared
between the two plans for each patient.
STATISTICS
Student T-test was used to compare difference in V30 for the rib
and chest wall and the pulmonary V20 between both plans for
each patient.
RESULTS
Patient demographics, CTV/PTV volumes, and distance of the
target from the chest wall are listed in Table 1. The results for
the V30 to the chest wall and ribs as well as the V20 to the
pulmonary parenchyma are demonstrated in Table 2. The abso-
lute volumes of rib, chest wall, and pulmonary parenchyma are
listed in Tables 3a,b,c, respectively. Individual patient maximum
tumor motion is listed in Table 4. All patients demonstrated
improvement in V30 for the chest wall and rib using VMAT plan-
ning. The average improvement to the chest wall was 74.3% and
to the ribs 60.8% using the VMAT plan (p < 0.05). Only one
patient demonstrated an increase in pulmonary V20 with the
VMAT plan.
DISCUSSION
Pain and discomfort of the chest wall can be a late effect of
radiation management and treatment of this effect can be unsat-
isfactory for both the patient and the physician. Often treatment
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Table 1 | Patient demographics and tumor statistics.
Patient (age
during treatment
time)
CTV(cc) PTV(cc) Tumor type Distance to the
closest rib (cm)
1 (91) 38 74.3 NSCL 0.8
2 (77) 17.9 43.3 Metastasis/
breast
2.2
3 (80) 16.1 49.8 NSCL 1.5
4 (74) 14.3 74.8 NSCL 2.5
5 (62) 11.4 35.1 NSCL 2.4
6 (64) 1.7 14.7 NSLC 2.8
7 (62) 0.9 9 Metastasis/
colon
1.0
8 (52) 9.2 38.5 NSCL 1.8
9 (84) 25.6 47 NSCL 2.0
10 (61) 4.7 18 NSCL 2.3
Average (71 years
old)
14.0 40.4 1.9
Table 2 | V30 for chest wall and ribs was reduced for all 10 patients
from original planning technique.
Patient Chest wall volume Ribs receive V20 lung dose (%)
receive >30Gy (%) >30Gy (%)
1 −65.5 −59.2 −2.4
2 −60.5 −91.1 −32.0
3 −32.2 −11.1 −6.5
4 −93.3 −51.4 12.6
5 −55.0 −47.9 −18.3
6 −57.0 −100.0 −54.1
7 −100.0 −69.1 −26.3
8 −62.1 −37.1 −3.9
9 −54.1 −40.9 −16.7
10 −55.6 −100.0 −52.0
V20 lung dose decreased for 9 of the 10 patients. The data is presented as the
percent decrease in volume treated using VMAT technology.
Table 3a | Rib volume receiving 30Gy.
Patient no. Hybrid SBRT (cc) RA SBRT (cc)
1 38.3 15.6
2 5.6 0.5
3 10.2 9.0
4 17.3 8.4
5 19.9 10.4
6 3.1 0.0
7 3.3 1.0
8 15.1 9.5
9 14.1 8.4
10 2.7 0
Average 13.0 6.3
Table 3b | Chest wall (2 cm) volume receiving 30Gy.
Patient no. Hybrid IMRT SBRT (cc) RA SBRT (cc)
1 501.6 139.7
2 30 3.1
3 134.1 65.7
4 347 56.3
5 330.6 56
6 56.7 0
7 17.1 7.7
8 247.7 55.8
9 219.2 72
10 55.4 20
Average 193.9 47.6
Table 3c | Percent lung volume receiving 20Gy.
Patient no. Hybrid IMRT SBRT (%) RA SBRT (%)
1 12.3 12.0
2 22.5 15.3
3 13.9 13.0
4 8.0 6.5
5 3.8 2.8
6 17.6 19.8
7 9.8 4.5
8 15.4 14.8
9 8.4 7.0
10 12.3 5.9
Average 12.4 10.2
Table 4 | Maximum tumor motion measured on 4D CT.
Patient no. 1 2 3 4 5 6 7 8 9 10
Motion (mm) 8.5 9 5 3 9.4 12.4 10.8 9.8 2 3
management options are limited to analgesia and nerve blocks,
each of which is often partially effective.
Traditional radiation therapy fractionation regimens can be
associated with the development of discomfort in the chest wall
and in more historical models rib fractures were identified on
occasion as part of breast cancer management (Dalinka et al.,
1974; Overgaard, 1988; Pierce et al., 1992; Hall, 2000; Jackson
et al., 2010). More modern radiation therapy treatment planning
strategies including volumetric treatment planning with inten-
sity modulation radiation therapy treatment execution permit
thorough examination of the radiation therapy dose to chest
wall structures, often permitting planning strategies to limit the
volume and extent of radiation dose inhomogeneity with the
chest wall target. These advances, including the use of inte-
grated advanced technology imaging techniques with real time
target validation, have permitted the field of radiation oncology
to re-visit the use of high dose limited fractionation treatment
schedules including stereotactic therapy formultiple body regions
and tumor targets. For tumor targets in close approximation to
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the chest wall, investigators are recognizing there is risk of injury
to the chest wall with accelerated fraction radiation therapy, espe-
cially when high volumes of the chest wall receive greater than
30 Gy. One series suggests that the risk of injury to the chest wall
with radiosurgery techniques is greater than 40% when lesions
are within 2 cm of the chest wall (Asai et al., 2012). Therefore,
when the tumor target is in close approximation to the chest wall,
there would be a higher risk using more traditional radiother-
apy technologies that use static fields as there would be more rib
and chest wall volume in the therapy field (Dalinka et al., 1974;
Overgaard, 1988; Pierce et al., 1992; Meric et al., 2002; Shioyama
et al., 2005; Zimmerman et al., 2006; Kyas et al., 2007; Baumann
et al., 2009; Petersson et al., 2009; Siva et al., 2010; Andolino et al.,
2011; Nambu et al., 2011; Stephans et al., 2012). This risk maybe
further exaggerated with larger PTVs needed for set up uncer-
tainty indicating the importance of immobilization and treatment
reproducibility. In our experience, we have found that person-
alized Vac-Loc with integrated wingboard works well for daily
reproducibility of patient set up coupled with shallow breath-
ing techniques. We have found that multiple compression devices
have introduced additional error into the patient set up and have
not demonstrated an advantage in patient care or reproducibil-
ity of each treatment. We identify the breathing cycle amplitude
during the simulation process and have successfully reproduced
the target with cone beam CT validation by re-establishing the
breathing amplitude cycle used at the time of simulation. In
patients with significant motion or change in respiratory status,
we perform a second simulation to validate that the ITV is iden-
tical to the volume established at the time of primary simulation.
To date, no patient has sustained a chest wall injury and none have
relapsed in the local target volume.
The use of modulated arc radiotherapy appears in our study
to have significant potential benefit for patient care in the sit-
uation where tumor comes in close approximation to the chest
wall region. VMAT can accommodate the multiple sloping sur-
faces of the chest wall and the dynamic nature of the simultaneous
dual motion of both the gantry and multileaf collimators permits
potentially more optimal radiation therapy treatment planning
and therapy execution. VMAT technology may decrease the risk
of injury to this selected patient population. In our study, signifi-
cant decreases in radiation dose to both chest wall and rib targets
were seen in side by side comparison between VMAT technology
and traditional SBRT treatment plans with static fields. Figures 1
and 2 demonstrate the improvement achievable in supine and
prone positions, respectively. In our analysis the average num-
ber of fields was seven (7) for non-VMAT planning. Another
FIGURE 1 | Demonstrates improvement in dosimetry in a lesion in the anterior segment of the left upper lobe with the static field plan on the left
and the VMAT plan on the right.
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FIGURE 2 | Demonstrates improvement in dosimetry to the chest wall and ribs in a patient in the prone position with a lesion in the posterior
segment of the right lower lobe. The static field plan is on the left and the VMAT plan is on the right.
advantage to VMAT therapy is speed of treatment delivery and
subsequent improvement in therapy dose rate. Traditional static
field radiosurgery treatment techniques with multiple fields can
take a significant amount of time to complete, often greater than
30min coupled with time for image validation. VMAT therapy
can take place in a much more abbreviated time frame (a few
min) further decreasing risk of target motion during therapy
as well as provide a more comfortable treatment environment
for the patient. The primary concern of arc therapy is in this
population that arc treatment will increase dose to pulmonary
parenchyma in patients treated with this technique. We note
only one patient experienced an increase in pulmonary V20 with
optimal VMAT planning relative to planning with static fields
(patient 4/12% increase). It is likely VMAT technology can play
an important role in hepatic radiotherapy when tumor comes in
close approximation to the chest wall as well as other tumor tar-
gets in multiple body locations that abut critical normal tissue
structures.
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